Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients
about
IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primatesThe lymph node in HIV pathogenesisCofilin activation in peripheral CD4 T cells of HIV-1 infected patients: a pilot studyIdiopathic CD4+ lymphocytopenia: natural history and prognostic factorsCD8 T cell persistence in treated HIV infectionHepatitis C Virus-Specific T-Cell Gamma Interferon and Proliferative Responses Are More Common in Perihepatic Lymph Nodes than in Peripheral Blood or LiverGenomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNAA mechanistic model for bromodeoxyuridine dilution naturally explains labelling data of self-renewing T cell populations.Determining thymic output quantitatively: using models to interpret experimental T-cell receptor excision circle (TREC) data.Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy.Chemokine coreceptor signaling in HIV-1 infection and pathogenesis.Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsetsThe effect of leflunomide on cycling and activation of T-cells in HIV-1-infected participants.HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment.Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Toll-like receptor 2/4 ligands.Innate immune recognition and activation during HIV infection.S-phase entry leads to cell death in circulating T cells from HIV-infected persons.Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection.Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies.Contribution of peaks of virus load to simian immunodeficiency virus pathogenesis.Dendritic cell-mediated viral transfer to T cells is required for human immunodeficiency virus type 1 persistence in the face of rapid cell turnoverIn vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.Long-term effects of intermittent IL-2 in HIV infection: extended follow-up of the INSIGHT STALWART Study.Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in PathogenesisHIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.Contribution of HIV infection to mortality among cancer patients in Uganda.Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes.CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway.Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cellsMechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection.Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.Cytokine therapies in HIV-1 infection: present and future.In vitro and in vivo effects of HIV protease inhibitors on apoptosis.Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV
P2860
Q24547172-74C2AC1D-0679-400A-93C8-F81B0AB2D40FQ24644783-53F91B20-61ED-42AB-9426-00CA4C83C8B3Q24645950-9D235805-33A3-44CD-B8F2-A5E8243E2F31Q24648099-BB891171-714E-47BD-AB69-648452E4BAD2Q27014768-A95B5093-64CA-4A8A-994A-2C87BDF18D08Q27487339-D7DDCA0D-0FC9-4102-A2DF-A7546527CE03Q28740542-6A6EB029-43E1-4A1A-91B9-DED4F17F92BEQ30571929-3BF401C1-C253-4F32-A7EA-6F24FB1A9B11Q31105898-6390F5B7-834F-4191-BDC9-D7B9A08298BCQ33326642-3C9CFB25-D4C9-4140-BFF1-73D975849180Q33507274-E0AE9142-0186-46DE-A198-BD3D8BAD1DDAQ33511372-C9D215E2-7505-4569-A479-A781E9DF6133Q33521304-BA3E1511-EF0D-49A2-825F-CD28AD94437BQ33591190-5572B60F-A351-4710-884F-629CC2A365B8Q33651140-61695800-DCEC-47C7-BC41-16311C215561Q33731771-3FF677AA-6DBB-457C-8AAA-A254B0875377Q33859760-23C8FC19-491C-4F4F-A68D-FD21F4A96914Q33987810-51EC826E-C54E-4053-B093-F7F33E2983C8Q33997880-22378AA5-3BDC-4185-8AD2-63DB66890123Q34020116-D625B911-A800-4157-B503-AAC111FC38FFQ34052036-254E990F-BCC4-494C-8318-A90993DFC327Q34075692-FE4C61F1-F89D-4413-B44E-85E57E02FBF2Q34255648-E631E24E-E66A-4C9E-9820-243B0746EE7CQ34331797-B0B8AD06-C072-48B0-BA78-4C9B3CFBBFE7Q34349275-39119392-426E-4BB2-AD87-EB4DA51A865DQ34387944-63E1E1CE-EE6C-4AB4-A028-A319DF01D48FQ34435083-C73326B9-F40E-414C-A2E5-A9578283AB64Q34452124-88709650-A0BE-43BC-BDD7-2AF9BB449C82Q34474320-5CD56996-F350-45FA-A60C-F679E2AF005CQ34841938-234F9429-879F-457A-897A-76BEDEBEEFBCQ35010983-3B456766-844D-4FE2-8828-92247814AEF4Q35056551-A2F28E37-1BE3-4EA1-B086-609F63B3C06DQ35112218-B460E0A7-7D2D-46B7-9108-FC52507C6945Q35115062-7BA4F2F7-15F6-401A-948C-01BE4D99271FQ35557198-6FC998FB-B579-47DF-97B7-3B1FC54D29CCQ35635026-859326DD-46F1-44E9-B939-39D28300366DQ35828692-9AF71CF1-970F-44D9-8A58-8556AA0D0F4FQ35917144-4E9484F8-7585-4ABA-B044-35F8943184A8Q36068283-697A9AB9-61FD-4D5A-944E-0D23EF71EAAAQ36369802-40CE98B7-A8ED-47CF-85B7-5474F5D68312
P2860
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Impact of HIV-1 infection and ...... nover in HIV-infected patients
@ast
Impact of HIV-1 infection and ...... nover in HIV-infected patients
@en
type
label
Impact of HIV-1 infection and ...... nover in HIV-infected patients
@ast
Impact of HIV-1 infection and ...... nover in HIV-infected patients
@en
prefLabel
Impact of HIV-1 infection and ...... nover in HIV-infected patients
@ast
Impact of HIV-1 infection and ...... nover in HIV-infected patients
@en
P2093
P2860
P356
P1476
Impact of HIV-1 infection and ...... nover in HIV-infected patients
@en
P2093
D S Dimitrov
J A Kovacs
J A Metcalf
J W Adelsberger
L A Lambert
M C Bosche
M W Baseler
R A Lempicki
R A Stevens
P2860
P304
13778-13783
P356
10.1073/PNAS.250472097
P407
P577
2000-12-01T00:00:00Z